Tripartite motif-containing protein (TRIM) family proteins are involved in a broad range of biological processes and, consistently, their alterations result in diverse pathological conditions such as genetic diseases, viral infection and cancer development. In this study, we found that one of the TRIM family proteins, TRIM31, is highly expressed in the gastrointestinal tract and interacts with p52
Introduction
Ubiquitination is a versatile posttranslational modification mechanism used by eukaryotic cells. The ubiquitin-proteasome pathway involves ubiquitin modification of substrates and sequential degradation by the proteasome [1] . Ubiquitin conjugation is catalyzed by ubiquitin-activating enzyme (E1), ubiquitin-conjugating enzyme (E2), and ubiquitin ligase (E3) [2] . E3 is a scaffold protein that mediates between the ubiquitin-linked E2 and the substrate. The resulting covalent ubiquitin ligations form polyubiquitinated conjugates that are rapidly detected and degraded by 26S proteasome [3] . E3 is thought to be most directly responsible for substrate recognition. E3 ubiquitin ligases so far identified include members of the HECT (homologous to E6-AP carboxyl terminus), RING-finger, and U-box protein families [4] [5] [6] .
TRIM31 is a member of the tripartite motif-containing protein (TRIM) family defined by the presence of a common domain structure composed of a RING finger, a B-box and a coiled-coil motif [7] . In addition to these motifs, TRIM31 possesses carboxy-terminal PRY and SPRY (Spla kinase and ryanodine receptor) domains.
TRIM family proteins are involved in a broad range of biological processes and, consistently, their alterations result in diverse pathological conditions such as genetic diseases, transcriptional regulation and cancer development [8] [9] [10] . It has been reported that TRIM31 shows the most rapid kinetics of induction during retinoid-induced growth arrest of breast carcinoma cell, and that it is upregulated in gastric adenocarcinoma and thought to be involved in the carcinogenesis [11, 12] .
However, the molecular function of TRIM31 has not been elucidated.
The Shc family proteins are important signal adaptors induced by various extracellular signals, such as signals from growth factors, cytokines and integrins, transmitting signals mainly to Ras activation [13] [14] [15] . Upon ligand binding, activated receptor tyrosine kinases recruit and phosphorylate Shc proteins, and then Shc proteins recruit downstream signaling molecules. The adapter protein Grb2, which is bound to the Ras GTP exchange factor Sos, is one of the well-known proteins that bind to Shc. Shc is involved in processes such as cell proliferation and differentiation by activating one of the effector downstream molecules of Ras [16] [17] [18] . Shc has three members, ShcA, ShcB and ShcC, each of which is encoded by three different genes [19] . ShcA is expressed in ubiquitous tissues, whereas ShcB and ShcC are expressed predominantly in neural tissues [19] [20] [21] Recombinant proteins and antibodies. His6-tagged TRIM31 was expressed in the Sf9 insect cell line using a baculovirus protein expression system (Invitrogen). The recombinant His6-tagged proteins were purified by using ProBond metal affinity beads (Invitrogen). The recombinant protein was used as immunogen in rabbits. Pulse-chase analysis with cycloheximide. Cells were cultured with cycloheximide (Sigma) at the concentration of 50 μg/ml and then incubated for various times. Cell lysates were then subjected to SDS-PAGE and immunoblot analysis with anti-FLAG,
anti-Myc and anti--actin antibodies.
Retrovirus expression system. Complementary DNAs encoding mouse TRIM31
containing FLAG-tags at their N-termini and human c-SrcY527F were subcloned into pMX-puro and pMX-hyg, respectively (all kindly provided by T. Kitamura, University of Tokyo), and the resulting vectors were used to transfect Plat E cells and thereby generate recombinant retroviruses [23] . NIH 3T3 cells were infected with the recombinant retroviruses and selected in a medium containing puromycin (2 μg/ml, Sigma).
Cell proliferation assay. NIH 3T3 cells (1 x 10 5 cells) in which TRIM31 or an empty vector (Mock) was stably expressed by using a retroviral expression system were seeded in 6-cm dishes and harvested for determination of cell number at indicated times.
Colony formation assay. For the colony formation assay, 5 10 4 cells were plated in 60-mm dishes containing 0.4% soft agar and cultured for 2 weeks. The numbers of colonies with a diameter of > 0.1 mm in randomized areas (1 cm 2 ) were counted.
were stained with a polyclonal anti-TRIM31 antibody or preimmune antibody and then Alexa488-conjugated goat antibody to rabbit immunoglobulin (Ig) (Invitrogen).
The cells were covered with a drop of GEL/MOUNT (Biomeda) and then photographed with a CCD camera (DP71, Olympus) attached to an Olympus BX51 microscope.
Statistical analysis. We used the unpaired Student's t test to determine the statistical significance of experimental data.
Results

TRIM31 is highly expressed in the gastrointestinal tract
It has been reported that TRIM31 is highly expressed in gastric adenocarcinomas and in the colon at the mRNA level [12] . To examine the expression levels of TRIM31 in several normal tissues at the protein level, we generated a rabbit polyclonal anti-TRIM31 antibody using recombinant mouse TRIM31 protein and performed immunoblot analysis using several normal mouse tissues. Interestingly, immunoblot analysis showed that mouse TRIM31 is highly expressed in the gastrointestinal tract ( Fig. 1A and C) . To further analyze the expression of TRIM31 in detail, we prepared several gastrointestinal tissues including esophagus, stomach, small intestine and large intestine tissues. Immunoblot analysis using cell extracts from these tissues showed that TRIM31 is expressed highly in the small intestine, moderately in the large intestine, and faintly in the stomach and esophagus (Fig. 1B) .
To clarify the distribution of TRIM31-positive cells in small intestine, we performed immunofluorescence analysis. immunofluorescence analysis showed that TRIM31 is highly expressed in the epithelial cells of small intestine (Fig. S1 ).
TRIM31 interacts with p52 Shc
To examine the molecular function of TRIM31, we isolated TRIM31-interacting proteins from an NIH 3T3 cDNA library by using a yeast two-hybrid system. We obtained 34 positive clones from 1.6 x 10 6 transformants. Five of the positive clones had sequence identities with cDNA encoding p52 Shc , which is one of the intracellular signal transducers. To examine whether TRIM31 physically interacts with p52 Shc in mammalian cells, we performed an in vivo binding assay using cells transfected with expression vectors. We expressed FLAG-tagged TRIM31 together with HA-tagged p52 Shc in HEK293T cells. Cell lysates were subjected to immunoprecipitation with an antibody to HA, and the resulting precipitates were subjected to immunoblot analysis with an antibody to FLAG. FLAG-TRIM31 was co-precipitated by the antibody to HA, indicating that TRIM31 specifically interacts with p52 Shc (Fig. 2A) .
We also verified the interaction between endogenous TRIM31 and endogenous p52 Shc by immunoprecipitation (Fig. 2B) . To further confirm the binding region of TRIM31 to p52 Shc , we constructed several deletion mutants of TRIM31 and compared their abilities to bind to p52 Shc (Fig. 2C ). An in vivo binding assay showed that deletion of the RING domain (TRIM31(56-507)) does not affect the binding to p52 Shc , whereas other deletion mutants abolish the binding to p52 Shc , indicating that almost the whole region other than the RING domain of TRIM31 is required for interaction with p52 Shc (Fig. 2D) .
TRIM31 does not affect the stability of p52
Shc TRIM31 has a RING-finger domain at its N-terminus and belongs to the TRIM family of proteins, some of which have been reported to be E3 ubiquitin ligases. To determine whether TRIM31 ubiquitinates p52 Shc and affects the stability of p52 Shc ,
we performed an in vivo ubiquitination assay and pulse-chase analysis. The in vivo ubiquitination assay revealed no significant enhancement of p52
Shc polyubiquitination with TRIM31 (data not shown), and pulse-chase analysis showed that TRIM31 does not affect the stability of p52 Shc (Fig. 3) . These findings suggest that the interaction of TRIM31 with p52
Shc does not relate to the ubiquitin-proteasome system.
TRIM31 does not affect cell proliferation but suppresses SrcY527F-mediated anchorage-independent growth.
Since it has been reported that p52 Shc stimulates colony formation but does not affect BrdU incorporation under the condition of PDGF stimulation, we first examined whether TRIM31 affects cell proliferation [24, 25] . We established an NIH 3T3 cell line in which FLAG-tagged TRIM31 was stably expressed by using a retroviral expression system (Fig. 4A ) Then the cells were seeded and the cell numbers were counted at indicated times (Fig. 4B) . Overexpression of TRIM31 did not affect cell proliferation compared with that of mock cells infected with the corresponding empty retrovirus (Fig. 4B) . It has been reported that p52 Shc stimulates colony formation and some of the Shc family proteins are direct activators of tyrosine kinase c-Src by an independent mechanism of dephosphorylation of phospho-Tyr-527 (Y527) [24, 26] . Therefore, we further established an NIH 3T3 cell line stably expressing the active form of Src (SrcY527F) by retroviral infection. The resulting cell line was further infected with retroviruses encoding FLAG-tagged TRIM31 or the corresponding empty vector (Mock). Expressions of FLAG-TRIM31
and SrcY527F in these cell lines were confirmed by immunoblot analysis (Fig. 4C) .
Overexpression of SrcY527F and/or TRIM31 did not affect cell proliferation (Fig.   4D ). Furthermore, these NIH 3T3 cell lines were seeded in a soft agar to examine their ability to undergo anchorage-independent growth. The cells infected with Mock or TRIM31 alone formed few colonies, whereas the cells expressing SrcY527F formed a number of colonies ( Fig. 4E and S2 ). The combination of SrcY527F and TRIM31 considerably decreased the ability for anchorage-independent growth, suggesting that TRIM31 partially attenuates tumorigenic activities by Src (Fig. 4E ).
Discussion
In this study, we found by yeast two-hybrid screening that TRIM31 interacts with p52 Shc and we found that TRIM31 affects anchorage-independent cell growth induced by the active form of c-Src. The transition to anchorage-independent cell growth is correlated with the potency of tumorigenicity and is widely recognized as an in vitro hallmark of oncogenic transformation [27, 28] . The Shc family proteins are important signal transducers activated by various extracellular signals [13] [14] [15] .
The protein p52 Shc is translocated to the plasma membrane from the cytosol upon stimulation such as stimulation with EGF, suggesting that p52 Shc is important for signal transduction to link the growth factor receptor to downstream molecules [29] . p52 Shc is also responsible for transducing anchorage-dependent growth signaling and may be involved in the adhesion process and metastasis of cancer cells [24, 30, 31] .
Integrins are important for mediating anchorage dependence, and several oncogene products, including active forms of Src, Rac1 and H-Ras, are required for inducing anchorage-independent growth [32] [33] [34] . It has also been reported that ShcA functions as a direct activator of tyrosine kinase c-Src, and the activation of Src by ShcA is not dependent on the phosphorylation of Y527, suggesting that ShcA positively regulates
Src by other mechanisms such as structural changes by direct interaction [24, 26] . As another possibility, c-Src may function as an upstream activator for ShcA [35] . Taken together, even though ShcA functions as an upstream activator or a downstream target of c-Src, our data in Fig. 4 are not contradictory. It has also been reported that TRIM31 overexpression suppresses colony formation of the human colon cancer cell line HCT116, while knockdown of its expression with short interfering RNAs slightly enhances growth of the pancreatic carcinoma cell line AsPC-1 [12] . Hence, these findings and our data suggest that TRIM31 attenuates c-Src-dependent activation in collaboration with ShcA for anchorage-independent growth.
It has been reported that cellular modification by ubiquitination has two different functions, a proteolytic role of substrates linked to proteasome machinery and a non-proteolytic role without proteasome machinery [36, 37] . We found by a binding assay that almost the whole region without the RING domain is required for binding to p52 Shc and we showed by pulse-chase analysis that overexpression of TRIM31 is not associated with the stability of p52 Shc . Furthermore, we did not find ubiquitination of p52 Shc by TRIM31 (data not shown). Therefore, these findings suggest that ubiquitination-mediated proteolysis of p52 Shc by TRIM31 does not affect the anchorage-independent cell growth induced by the active form of c-Src. Direct physical binding of TRIM31 to p52 Shc may inhibit c-Src-mediated cell activation.
It has been reported that TRIM31 is highly expressed in gastric cancer and chronic gastritis, in which proliferation and apoptosis are likely to be dysregulated [12] . We showed high expression of TRIM31 in normal gastrointestinal tracts including the stomach, small intestine and large intestine. TRIM31 may play an important role in gastrointestinal tissue-specific regulation of cell proliferation. Further investigations are needed to clarify the mechanisms for the time-dependent expressions of gastrointestinal tissues.
In conclusion, TRIM31 is a novel regulator affecting anchorage-independent cell growth, and results of further studies on TRIM31 may be useful for revealing the growth activity of cells in the gastrointestinal tract. Moreover, analysis by a genetic approach using transgenic or knock-out mice is needed to determine whether TRIM31 functions as a regulator of anchorage-independent cell growth. 
